Towards the transcriptome - without arrays
The market for non-array products used in the analysis of the
transcriptome - a map of gene expression and mRNA in the cell - is
maturing quickly but will still grow at more than 14 per cent a
year between 2003 and 2008, says a report...
Millipore 2Q sales up but biotech static
Millipore has reported buoyant sales growth in the second quarter
of this year but was let down by a lacklustre showing from its
biotechnology division, held up as one of the key drivers of future
Therascope raises €24m for drug discovery
Therascope, a privately held biopharmaceutical company focused on
small molecule drug discovery, has raised €24.1 million to develop
its TACE platform.
Tecan links with EMD for proteomics tools
Switzerland's Tecan has forged a co-marketing alliance with EMD
Biosciences in the area of automated systems for medium- to
high-throughput protein extraction, screening and purification. The
collaboration will focus on companies...
First CYP450 structure published
Astex Technology has published the first three-dimensional study of
a human cytochrome P450 protein involved in drug metabolism in the
Caliper completes Zymark purchase
Caliper Technologies has completed its $71 million (€61m)
acquisition of Zymark, a privately held provider of laboratory
automation, liquid handling and robotics systems.
Biomarker study shows drug causes apoptosis
An inhibitor of cyclin dependent kinase (CDK) originated by UK
biopharmaceutical company Cyclacel has generated encouraging data
in a Phase I trial.
Biofrontera buys natural compound firm
Biofrontera Pharmaceuticals has taken over the entire operations of
bioLeads, a company specialising in sourcing natural compounds from
EC unveils €411m fund for genomics research
The European Commission has published a call for research proposals
in the area of life sciences, genomics and biotechnology for
Tissue microarray use on the rise
There is a growing reliance on the use of tissue microarrays to
accelerate the examination of histological samples used in drug
discovery, according to a new report from BioInformatics.
Ambion launches first SARS control
RNA specialist Ambion has introduced what it claims is the first
commercially available positive control for use in the detection of
the SARS virus.
Plant compounds for cancer control
MolecularNature has forged a drug discovery partnership with Zetiq
Technologies that has already yielded a number of novel cancer
ALA LabFusion springs from ISLAR ashes
This year's ISLAR meeting - the last ever to be held - will be
replaced in 2004 by a new Association of Laboratory Automation
conference called LabFusion.
Karo Bio cuts losses as R&D progresses
Swedish drug discovery company Karo Bio has trimmed its losses down
to SEK18.1 million in the second quarter of 2003 from SEK79.7
million a year earlier.
EU states taken to ECoJ over biotech
European Commission refers eight EU member states to the European
Court of Justice over their alleged failure to implement legal
protection of biotech inventions.